AU
UK
CA
US
IND
NZ
Last update at 2025-07-17T13:08:57.169629Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown | 2022-12-31 | 2021-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 |
| Investments | - | - |
| Change to liabilities | - | - |
| Total cashflows from investing activities | - | - |
| Net borrowings | - | - |
| Total cash from financing activities | - | - |
| Change to operating activities | - | - |
| Net income | 26.05M | -1.79280M |
| Change in cash | - | - |
| Begin period cash flow | - | - |
| End period cash flow | - | - |
| Total cash from operating activities | - | - |
| Issuance of capital stock | - | - |
| Depreciation | - | - |
| Other cashflows from investing activities | - | - |
| Dividends paid | - | - |
| Change to inventory | - | - |
| Change to account receivables | - | - |
| Sale purchase of stock | - | - |
| Other cashflows from financing activities | - | - |
| Change to netincome | - | - |
| Capital expenditures | 0.00000M | 0.00000M |
| Change receivables | - | - |
| Cash flows other operating | - | - |
| Exchange rate changes | - | - |
| Cash and cash equivalents changes | - | - |
| Change in working capital | - | - |
| Stock based compensation | - | - |
| Other non cash items | - | - |
| Free cash flow | - | - |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | ||
|---|---|---|---|---|---|---|---|---|
| AGBIF Atlas Global Brands Inc. |
- -% | - | - | - | 3.55 | - | ||
| ZTS Zoetis Inc |
1.20 1.57% | 77.59 | 40.18 | 30.96 | 10.67 | 17.60 | 11.27 | 26.18 |
| MKKGY Merck KGaA ADR |
0.58 1.91% | 31.01 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% | 153.91 | 21.73 | 14.95 | 3.16 | 2.15 | 3.56 | 12.82 |
| GALDY GALDERMA GROUP AG |
-0.79 1.89% | 40.92 | 74.21 | 41.67 | 8.64 | 5.55 | 9.15 | 42.22 |
Atlas Global Brands Inc. engages in the production, distribution, and sale of cannabis in Canada, Australia, Germany, Israel, Denmark, Norway, Spain, and the United Kingdom. It is involved in cannabis cultivation, manufacturing, marketing, distribution, and pharmacy activities, as well as provision of cannabis for the adult recreational market. The company offers its products under the D*gg Lbs, GreenSeal, Electric Lettuce, and BONFIRE brands. Atlas Global Brands Inc. is headquartered in Chatham, Canada.
566 Riverview Drive, Chatham, ON, Canada, N7M 0N2
| Name | Title | Year Born |
|---|---|---|
| Mr. Bernard Yeung M.B.A. | CEO, GM & Head of Global Operations | NA |
| Mr. Jason Cervi CPA | CFO & Head of Administration | NA |
| Mr. Jeffrey R. Gossain | Chief Operating Officer | NA |
| Dr. Trevor Henry D.V.M. | Director & President of AgMedica | NA |
| Ms. Natalie Douglas | Corporate Secretary | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...